US 10927435
Compositions for the treatment of rheumatoid arthritis and methods of using same
granted A61KA61K31/42A61K31/519
Quick answer
US patent 10927435 (Compositions for the treatment of rheumatoid arthritis and methods of using same) held by REGENERON PHARMACEUTICALS, INC. expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/42, A61K31/519, A61K31/655, A61K39/39541